AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lindbrook Capital, LLC | 98 | $1,615 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 450 | $7,416 | 0.00% |
| WELLS FARGO & COMPANY/MN | 30,100 | $496,048 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 80,402 | $1,325,024 | 0.00% |
| Corient Private Wealth LLC | 10,439 | $172,035 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 42,681 | $703,384 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 8,506 | $140,179 | 0.00% |
| Parallel Advisors, LLC | 42 | $692 | 0.00% |
| WOLVERINE TRADING, LLC | 17,600 | $261,184 | 0.00% |
| WOLVERINE TRADING, LLC | 24,200 | $359,128 | 0.00% |
| WOLVERINE TRADING, LLC | 16,453 | $244,163 | 0.00% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q2 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.